Treatment of childhood cancer in China: Current status and future direction-Reference-Cited by-同舟云学术

Treatment of childhood cancer in China: Current status and future direction

Published:2020-09 Issue:3 Volume:4 Page:153-156
ISSN:2574-2272
Container-title:Pediatric Investigation
language:en
Short-container-title:Pediatr. Invest.

Author:

Li Chi‐kong¹,Tang Jingyan²,Zheng Huyong³,Fang Jianpei⁴,Sun Xiaofei⁵

Affiliation:

1. Department of Paediatrics The Chinese University of Hong Kong Hong Kong Children’s Hospital Hong Kong China

2. Department of Hematology/Oncology Shanghai Children’s Medical Centre Shanghai Jiao‐Tong University School of Medicine National Center for Children’s Health China

3. Hematology Oncology Center Beijing Children’s Hospital Capital Medical University National Center for Children’s Health China

4. Department of Pediatrics Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

5. Department of Pediatric Oncology Sun Yat‐Sen University Cancer Center Guangzhou China

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ped4.12210

Reference15 articles.

1. Communique of the National Bureau of Statistics of People’s Republic of China on major figures of the 2010 population census (No. 1);National Bureau of Statistics of China;China Popul Today,2011

2. Incidence, mortality and survival of childhood cancer in China during 2000–2010 period: A population-based study

3. Paediatric cancer in low-income and middle-income countries

4. Professor Ya-mei Hu

5. Pediatric Medical Care System in China Has Significantly Reduced Abandonment of Acute Lymphoblastic Leukemia Treatment

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inborn errors of immunity and its clinical significance in children with lymphoma in China: a single-center study;Jornal de Pediatria;2024-07

2. Financial burden faced by breastfeeding mothers caring for children diagnosed with cancer in Ghana; an exploratory qualitative study;BMC Women's Health;2024-03-14

3. Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study;Drugs in R&D;2023-05-10

4. Psychosocial outcomes in Chinese survivors of pediatric cancers or bone marrow failure disorders: A single-center study;PLOS ONE;2022-12-13

5. Diagnosis and outcomes of pediatric central nervous system tumors in China: a single-center retrospective analysis from 2015 to 2020;Pediatric Medicine;2022-08